Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

Market Cap	13.31B
Revenue (ttm)	2.13B
Net Income (ttm)	449.21M
Shares Out	245.35M
EPS (ttm)	1.83
PE Ratio	29.69
Forward PE	n/a
Dividend	1.07 (1.94%)
Ex-Dividend Date	May 22, 2025

Volume	5,171,114
Average Volume	7,983,027
Open	51.61
Previous Close	55.26
Day's Range	51.61 - 55.69
52-Week Range	46.34 - 142.86
Beta	0.33
RSI	50.12
Earnings Date	Aug 29, 2025

About SHE:300573

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China. The company develops ophthalmic anti-infective drugs, other ophthalmic drugs, nonsteroidal anti-inflammatory drugs for ophthalmology, mydriatic and ciliary muscle paralytic drugs, ophthalmic anti-inflammatory/anti-infective compound drugs, dry eye products, miotic and anti-glaucoma drugs, and other drugs. It also develops products, such as Zirun, a Cyclosporine eye drops; Sugaojie, a calf bl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1977
• Employees: 2,426
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300573

Financial Performance

In 2024, SHE:300573's revenue was 1.94 billion, an increase of 32.42% compared to the previous year's 1.47 billion. Earnings were 338.06 million, an increase of 40.84%.